NL-OMON24250RecruitingNot Applicable
Pre-Eclampsia and other Risk FactORs in relation to Migraine
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Erasmus Medical Center
- Enrollment
- 600
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •Postpartum normotensive women or women with uncomplicated preexisting hypertension (group 1):
- •- Postpartum female adults aged =18 years;
- •- Women should either be normotensive or suffer from uncomplicated preexisting hypertension;
- •- Capable of understanding the purpose of the study, fully informed and given written informed consent (signed Informed Consent Form has been obtained).
- •A subset of group 1 will be asked to participate in the second part of the PERFORM study, which comprises the objective and subjective assessment of cognitive functioning and decline at the Erasmus MC. This subset of participants should include women who have had an uncomplicated and natural, non-assisted vaginal delivery (with a healthy baby born between 37 and 41 weeks). These women should also have had no complications during pregnancy and delivery, including hypertension or ruptures, which might have affected their mental state.
- •Postpartum women with (severe) pre-eclampsia, gestational hypertension, or superimposed hypertension/pre-eclampsia (group 2):
- •- Postpartum female adults aged =18 years;
- •- Postpartum women who have experienced a severe form of pre-eclampsia during pregnancy, or gestational hypertension, or superimposed hypertension/pre-eclampsia;
- •- Capable of understanding the purpose of the study, fully informed and given written informed consent (signed Informed Consent Form has been obtained).
- •All subjects of group 2 will be asked to participate in the second part of the PERFORM study, which comprises of the objective and subjective assessment of cognitive functioning and decline.
Exclusion Criteria
- •A (new) pregnancy within the first year after inclusion for the PERFOM study.
Investigators
Similar Trials
Completed
Not Applicable
Risk calculation for Pre-Eclampsie and Grwoth Restriction in the First TrimesterPre-eclampsia - New-onset Hypertension and Proteinuria in Pregnancy1001027310057166NL-OMON39085niversitair Medisch Centrum Groningen3,000
Not yet recruiting
Phase 3
A Prospective PreecLampsia/Eclampsia Preventative Intervention – Metformin (APPLE PIE) studyPregnancy and ChildbirthPACTR202107604428217Stellenbosch University1,430
Completed
Not Applicable
The risk of preoparative factors influencing postoperative complications and early mobilization undergoing thoracic and abdominal surgery.Patients undergoing thoracic and abdominal surgeryJPRN-UMIN000021875agasaki University1,000
Withdrawn
Phase 3
A Prospective, Pre-ecLampsia/Eclampsia Prevention IntervEntioACTRN12618000690257niversity of Melbourne (through its Department of Obstetrics and Gynaecology)5,500
Completed
Not Applicable
Prediction of preeclampsia and adverse eventspreeclampsiatoxemia10026908NL-OMON48757eids Universitair Medisch Centrum400